Xu Jun, Qiu Ruoyi, Garces Alexander M, Hübner Harald, Xu Xinyu, Weikert Dorothee, Gmeiner Peter, Lerch Michael T, Kobilka Brian K
bioRxiv. 2025 Sep 11:2025.09.10.675278. doi: 10.1101/2025.09.10.675278.
The α adrenergic receptor (α AR) is a clinically important target for various diseases including hypertension, diabetes and chronic pain. Here, using single-molecule fluorescence resonance energy transfer imaging, we show how agonist-specific activation dynamics in both structured transmembrane domain (TMD) and intrinsically disorders regions (IDRs) of α AR lead to diverse signaling profiles. Through seven pairs of strategically designed fluorophore labels, we systematically investigate the real-time conformational changes of α AR. Our study reveals unique TM6 dynamics in α AR, featured by a high energy barrier for agonist-induced outward movements essential for activation. In contrast, we identify agonist-specific conformational dynamics of a partially disordered extracellular loop (ECL2), highlighting its role as a dynamic regulatory module that controls receptor function. Moreover, we characterize the conformational landscapes of the long third intracellular loop (ICL3), revealing its compact structural features and membrane-proximal localization in the basal state, where it acts as a negative allosteric regulator in transducer coupling. Furthermore, we identify multiful functional sub-states of ICL3 that are dynamically modulated by both kinase phosphorylation and drug efficacy. These findings offer previously underappreciated structural and dynamic insights into α AR function governed by both TMD and IDRs, and may open up new avenues for the development of better therapeutics.
α肾上腺素能受体(α-AR)是包括高血压、糖尿病和慢性疼痛在内的多种疾病的重要临床靶点。在此,我们利用单分子荧光共振能量转移成像技术,展示了α-AR的结构化跨膜结构域(TMD)和内在无序区域(IDR)中激动剂特异性激活动力学如何导致不同的信号转导谱。通过七对精心设计的荧光团标签,我们系统地研究了α-AR的实时构象变化。我们的研究揭示了α-AR中独特的TM6动力学,其特征是激动剂诱导的向外运动存在高能量屏障,而这种运动对于激活至关重要。相比之下,我们确定了部分无序的细胞外环(ECL2)的激动剂特异性构象动力学,突出了其作为控制受体功能的动态调节模块的作用。此外,我们表征了长的第三细胞内环(ICL3)的构象景观,揭示了其在基础状态下的紧密结构特征和膜近端定位,在该状态下它作为转导偶联中的负变构调节剂发挥作用。此外,我们确定了ICL3的多种功能亚状态,这些亚状态受到激酶磷酸化和药物疗效的动态调节。这些发现为TMD和IDR共同调控的α-AR功能提供了前所未有的结构和动态见解,并可能为开发更好的治疗方法开辟新途径。